RTTNews | Nov 26, 2021 07:25AM EST

07:25 Friday, November 26, 2021 (RTTNews.com) - Can-Fite BioPharma Ltd. (CANF) on Friday reported net loss of $8.49 million for $0.02 per share for the 9-month period ended September 30, 2021, narrower than $11.53 million or $0.04 per share in the same period last year, primarily due to decrease in research and development expenses.

Research and development expenses for the nine months period were $6.75 million compared with $9.06 million for the same period in the prior year.

Revenue for the period was $0.65 million compared with $0.61 million a year ago.

On September 30, 2021, Can-Fite had about $13.3 million in cash, cash equivalents, and short-term deposits.

Read the original article on RTTNews ( https://www.rttnews.com/3245045/can-fite-biopharma-reports-narrower-loss-for-9-months.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved